Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
Don’t Miss a Move in the ETF Market
Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.
XGEN ETF · Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -3.25%  | -5.04%  | +21.53%  | +8.01% | N/A | +1.54% | +1.54% | -4.39% | |
| Flows |
Key fund info
Enterprise
Similar ETFs
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -5.04% | +21.53%  | +8.01% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about XGEN ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
XGEN’s has a Final Sustainability Grade of either A+, A, or A-.
Replication
Issuer
| AuM | ||
|---|---|---|
XEON | Xtrackers II EUR Overnight Rate Swap UCITS ETF | €20.35B |
XDWD | Xtrackers MSCI World UCITS ETF | €16.48B |
XMME | Xtrackers MSCI Emerging Markets UCITS ETF | €9.43B |
XD9U | Xtrackers MSCI USA UCITS ETF | €9.19B |
XDEW | Xtrackers S&P 500 Equal Weight UCITS ETF | €9.06B |
Frequently asked questions about XGEN
What does Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF, XGEN, invest in?
XGEN is a Passive ETF. This ETF provides exposure to Other Equities.
Which benchmark or index does XGEN replicate?
XGEN tracks the MSCI ACWI IMI Genomic Innovation Select Screened 100 Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of XGEN?
XGEN carries a total expense ratio (TER) of 0.3%, indicating the annual cost for holding the fund.
When was XGEN launched?
XGEN was introduced to the market on July 12, 2022. It trades on Sweden, among other exchanges
Who is the ETF issuer of XGEN?
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF, XGEN, is provided by Xtrackers by DWS. Learn more about Xtrackers by DWS here.
What is the current assets under management (AUM) of XGEN?
XGEN oversees €7.7M in assets as of April 1, 2026.
How has XGEN performed lately?
Based on data from April 1, 2026, XGEN returned -3.25% over the past month, -5.04% over the last three months and -4.39% year-to-date.
What are the latest inflows or outflows for XGEN?
As of April 1, 2026, XGEN recorded net flows of +€2.1M over the last month and +€2.1M year-to-date.
Does XGEN distribute dividends?
XGEN follows a capitalizing, meaning it reinvests income within the fund.
What are the main country or region exposures of XGEN?
As of February 28, 2026, XGEN has significant geographic allocations in USA, Switzerland and Cayman Islands.
In which sector or theme does XGEN invest in?
As of February 28, 2026, XGEN focuses largely on Health Care.
How many securities does XGEN hold and how diversified is it?
As of February 28, 2026, XGEN holds 99 positions in its portfolio, with 56.66% of assets concentrated in its top 15 holdings.
What are the main positions in XGEN?
As of February 28, 2026, XGEN top three holdings include ROCHE, VERTEX PHARMACEUTICALS and NATERA.
What is the base currency of XGEN?
The base currency of XGEN is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
